首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   34687篇
  免费   3550篇
  国内免费   4939篇
  2024年   24篇
  2023年   451篇
  2022年   638篇
  2021年   1737篇
  2020年   1362篇
  2019年   1740篇
  2018年   1582篇
  2017年   1227篇
  2016年   1663篇
  2015年   2417篇
  2014年   2911篇
  2013年   3005篇
  2012年   3628篇
  2011年   3290篇
  2010年   2110篇
  2009年   1877篇
  2008年   2103篇
  2007年   1889篇
  2006年   1652篇
  2005年   1351篇
  2004年   1106篇
  2003年   1037篇
  2002年   871篇
  2001年   547篇
  2000年   472篇
  1999年   433篇
  1998年   277篇
  1997年   254篇
  1996年   219篇
  1995年   182篇
  1994年   178篇
  1993年   123篇
  1992年   132篇
  1991年   104篇
  1990年   78篇
  1989年   76篇
  1988年   61篇
  1987年   40篇
  1986年   51篇
  1985年   60篇
  1984年   23篇
  1983年   29篇
  1982年   29篇
  1981年   23篇
  1980年   10篇
  1979年   20篇
  1978年   9篇
  1974年   8篇
  1973年   11篇
  1971年   8篇
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
991.
992.
993.
Bone morphogenetic protein (BMP)2/7 heterodimer shows greater efficacy in enhancing bone regeneration. However, the precise mechanism and the role of mitogen-activated protein kinase (MAPK) signaling network in BMP2/7-driven osteogenesis remain ambiguous. In this study, we evaluated the effects of BMP2/7 heterodimers on osteoblastic differentiation in rat bone marrow mesenchymal stem cells (BMSCs), with the aim to elaborate how MAPKs might be involved in this cellular process by treatment of rat BMSCs with BMP2/-7 with a special signal-pathway inhibitor. We found that BMP2/7 heterodimer induced a much stronger osteogenic response in rat BMSCs compared with either homodimer. Most interestingly, extracellular signal-regulated kinase (ERK) demonstrated a highly sustained phosphorylation and activation in the BMP2/7 heterodimer treatment groups, and inhibition of ERK cascades using U0126 special inhibitor that significantly reduced the activity of ALP and calcium mineralization to a substantial degree in rat BMSCs treated with BMP2/7 heterodimers. Collectively, we demonstrate that BMP2/7 heterodimer shows a potent ability to stimulate osteogenesis in rat BMSCs. The activated ERK signaling pathway involved in this process may contribute partially to an increased osteogenic potency of heterodimeric BMP2/7 growth factors.  相似文献   
994.
995.
Colorectal cancer is considered as the fourth leading reason of cancer-linked deaths worldwide. However, our knowledge about its pathogenic mechanism remains inadequate. MicroRNA 32 (miR-32), a member of small noncoding RNAs, has been found vital roles in tumorigenesis. This study studied its functions and underlying mechanism in colorectal cancer. The experiment revealed the obvious upregulation of miR-32 in colorectal cancer tissues and six cancer cell lines, compared with normal tissues and cells. Moreover, miR-32 upregulation reduced cell apoptosis and promoted cell proliferation and migration, while its downregulation displayed opposite effects. Dual luciferase reporter assays proved that miR-32 bound to the 3′-untranslated region (3′-UTR) of OTU domain containing 3 (OTUD3), suggesting that miR-32 directly targeted OTUD3. Further experiments demonstrated that overexpression of miR-32 could reduce the expression level of OTUD3. Furthermore, OTUD3 silence promoted proliferation and motility and decreased apoptosis for HCT116 cells and restored partly miR-32-mediated cell proliferation, migration, and antiapoptosis for colon cancer. Therefore, our study indicated that miR-32 enhanced cell proliferation and motility abilities, and inhibited apoptosis by directly targeting OTUD3 in colon cancer cells, which implied that miR-32 was hopeful to be a biomarker or target used for diagnosis and therapy of colon cancer.  相似文献   
996.
997.
998.
999.
1000.
Peng  Wei  Xu  Shangrong  Zhang  Jun  Zhang  Yong 《Biological trace element research》2019,188(1):189-195
Biological Trace Element Research - The thioredoxin-like (Rdx) family proteins contain four selenoproteins (selenoprotein H, SELENOH; selenoprotein T, SELENOT; selenoprotein V, SELENOV;...  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号